Celebrating the First Anniversary of Cancer Innovation

With the publication of Volume 2, Issue 3 in June 2023, Cancer Innovation, sponsored by Tsinghua University, published by Tsinghua University Press and distributed internationally by Wiley, is celebrating its first anniversary!

Against the background of "Cancer has always been an important factor threatening human health" and "Technological innovation has become a major national development strategy", Cancer Innovation emerged. After 8 months of intensive  preparation, Cancer Innovation published its 1st issue on June 30, 2022.

Cancer Innovation has received more than a hundred submissions around the world and published a total of 62 high quality papers to date, including 24 reviews, 20 original articles, 7 case reports, 6 commentaries, 2 clinical guidelines, 1 Meta analysis, 1 news and 1 editorial. As an open access journal, Cancer Innovation shared the up-to-date research progress with readers located in more than 70 countries worldwide, including China, USA, India, UK, Korea, Japan, Australia, Germany, Norway, etc.

In 2022, with the consistent help and support of Tsinghua University, Tsinghua University Press, Boao Cancer Innovation Institute and Wiley, especially with the strong and consistent support from more than 70 editorial board members and more than 80 emerging editorial board members from China, USA, UK, Australia, Canada, Russia, Ireland, Singapore, Japan and Mongolia, Cancer Innovation has been growing rapidly and reaped a series of congratulatory achievements:

  • In September 2022, Cancer Innovation was selected as one of the "2022 China Science and Technology Journal Excellence Action Plan High Start Journals" and "Tsinghua University World Class Science and Technology Journal Cluster Development Plan";
  • In October 2022, Cancer Innovation was accepted by Scopus and indexed by the Directory of Open Access Journals (DOAJ);
  • In February 2023, Cancer Innovation was indexed by CAS (Chemical Abstracts Service).

With the accumulating innovation and development of medical technology, big data applications, interdisciplinary collaboration, the field of oncology and related disciplines are rapidly advancing and making significant progress. Along with these successes, cancer science is also facing challenges such as the diversity and heterogeneity of tumors, side effects of treatments, and uneven distribution of health resources. Cancer Innovation continuously strive to create an open, innovative, equal, and inclusive platform, to become a high-quality platform for publishing and disseminating the latest research results and concepts in the field of oncology and related interdisciplinary fields, to promote scientific research and technological innovation, and to facilitate international exchanges and cooperation in oncology and related interdisciplinary fields. This is going to reduce the incidence and mortality of cancer as well as to improve the life quality and health level of people globally and promote health equity.

At the moment of the first anniversary of Cancer Innovation's launch, we sincerely invite you to continue to stay updated on and support the growth and development of this journal through manuscript submission, recommendation of editorial board members, academic cooperation, and other ways. We look forward to working with you to promote the progress and development of oncology and related disciplines!



Editor-in-Chief, Cancer Innovation